|Day Low/High||41.35 / 42.49|
|52 Wk Low/High||21.50 / 300.00|
There are some big shifts Wednesday in names that have recently been the hottest.
Let's check out the charts of four big names in the space.
CBD could make coffee an around the clock craze.
Canopy Growth's smoking engine won't necessarily ensure smooth sailing for Constellation.
"One last thing." -- Lt. Columbo I have recently been focused on Canopy Growth Corp. CGC as an interesting speculation in 2019 (I have been adding over the last few days). In fact, I commented today on the stock. After the close, Tilray was upgraded...
In the interest of due diligence, we went and took a close look at the ground floor of the newest investment craze.
Establishing who the stragglers are and what impact they might have in the future is the key at this point.
I'd be most interested in buying this name after a cap raise which I expect in the first quarter of 2019.
Perhaps no company has bought into the Canadian cannabis craze more than Constellation Brands.
The buy-in from other companies into the space has been far larger.
Tilray's technical history is limited, but a bullish divergence in a key chart could be foreshadowing a rally ahead.
Pot stock partnerships are a gateway to gains for cannabis investors.
Things could get interesting as the end of 2018 approaches.
The tobacco giant is being threatened on two fronts: e-cigarettes in the form of Juul and cannabis.
White House Politics: (When asked what he wanted to give thanks for during a press gaggle Thanksgiving Thursday, Trump responded), "for having a great family and for having made a tremendous difference in this country. I've made a tremendous differe...
The wave of names going public is leaving investors confused and overwhelmed.
Shares of Tilray, Canopy Growth and Aurora Cannabis are down sharply on Wednesday.
Cannabis' strong shift on midterms offers hope for pot stocks to play in America.
If Tilray happens to gap up on earnings I expect it will be sold aggressively.
Shorts aren't shying away from the cannabis industry even after a series of squeezes.
Perhaps the highest profile impact on Tilray equity performance has been the interest of Andrew Left of Citron Research.
Here's why I favor the upside in TLRY stock going forward.
Tilray will have a lot to tackle this evening.
The never-ending strength now seen in the dollar is causing the most pain in U.S. markets.
Consumer Discretionary stocks were the hottest on Wednesday, though all eleven sectors easily finished in the green.
An early look at the market shows supply is finding it tough to keep up with demand.
A bunch of pot stocks are in play on Tuesday -- for a reason.
The stock closed down on its first day of trading on the CSX. Here is a breakdown of the current landscape and some up-and-comers to keep an eye on.